Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Pharmacovigilance Market Value Expansion And Long-Term Growth Outlook
The pharmacovigilance sector has experienced swift expansion over the last few years, advancing from a valuation of $9.64 billion in 2025 to an estimated $10.86 billion in 2026, reflecting a compound annual growth rate (CAGR) of 12.7%. This upward trajectory during the historical phase is largely driven by heightened adverse drug reaction reporting, a broader scope of pharmaceutical approvals worldwide, an uptick in clinical trial activities, the development of global drug safety standards, and increased consumption of medications for chronic conditions.
The pharmacovigilance market is forecast to experience significant growth over the coming years, with projections indicating it will reach a value of $17.41 billion by 2030, expanding at a compound annual growth rate (CAGR) of 12.5%. This anticipated expansion during the forecast period is driven by factors such as the increased use of real-world data, a rise in approvals for biologics and biosimilars, the growing complexity of combination therapies, the broadening of pharmacovigilance activities within emerging markets, and a heightened emphasis on patient safety outcomes. Key developments expected in this period include the broadening of post-marketing surveillance initiatives, a greater reliance on real-world evidence for safety monitoring, tighter regulatory oversight and adherence requirements, a rising trend toward outsourcing pharmacovigilance services, and the merging of safety data from multiple sources.
Download A Free Sample Report For Comprehensive Market Insights:
Pharmacovigilance Market Expansion Drivers: What Is Shaping Future Growth?
The pharmacovigilance market is being fuelled by an increase in research and development activities. Through investment in R&D, pharmaceutical companies are able to create new and innovative drugs that feature enhanced safety profiles. Potential safety issues are identified early on through rigorous preclinical and clinical testing conducted during the drug development process, which enables the implementation of suitable risk mitigation strategies. Furthermore, R&D efforts contribute to progress in technologies designed for adverse event monitoring, data analysis, and signal detection, making it easier to spot adverse drug reactions early in the post-marketing phase. As an example, in 2023, the Office for National Statistics, a UK-based government agency, reported that the UK government’s net R&D spending rose to £17.4 billion from £16.1 billion in 2022, representing an 8.2% increase. Consequently, the growth of the pharmacovigilance market was supported by these expanding research and development activities.
Pharmacovigilance Market Segmentation And Category Breakdown
The pharmacovigilance market covered in this report is segmented –
1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
2) By Service Provider: In-House, Contract Outsourcing
3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
5) By End User: Hospitals, Pharmaceutical Companies, Other End Users
Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies
5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems
Pharmacovigilance Market Strategic Trends: What Is Defining The Next Phase Of Growth?
Key players in the pharmacovigilance market are increasingly turning to artificial intelligence (AI) to boost operational efficiency. By enhancing both the precision and speed of pharmacovigilance tasks, AI contributes to improved patient safety outcomes. Pharmaceutical firms leverage this technology to refine their workflows, enhance data handling, speed up drug development, and cut expenses while strengthening safety protocols. A notable example occurred in August 2024, when India’s government unveiled the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare along with the Minister of Chemicals and Fertilizers. This pharmacovigilance tool enables the gathering and analysis of adverse events linked to medications and medical devices, simplifying reporting for consumers and healthcare workers alike. Such an initiative greatly bolsters India’s pharmacovigilance framework by enabling more thorough safety data collection and reinforcing drug safety oversight. The ADRMS is intended to elevate the effectiveness of drug safety compliance and regulatory standards, thereby positioning India as a frontrunner in the worldwide pharmaceutical sector.
Pharmacovigilance Market Competitive Analysis Of Major Industry Participants
Major companies operating in the pharmacovigilance market are IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation, United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Secure AI Labs, OmniSol dot Tech, Prevnos Inc., Lifescient Inc, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., Novasyte, Fortrea Holdings Inc., Syneos Health Clinical, Telerx Marketing Inc.
Access The Complete Pharmacovigilance Market Report:
Pharmacovigilance Market Regional Distribution: Which Areas Drive Market Expansion?
North America was the largest region in the pharmacovigilance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model